Andrew Paine

Work Performance Price Targets & Ratings Chart

Analyst Andrew Paine, currently employed at CLSA,

Most recent stock forecast was given on RMD, ResMed at 17-Jul-2025.

Wall Street Analyst Andrew Paine

Analyst best performing recommendations are on RMD (RESMED).
RMD ResMed

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$290

$35.6 (13.99%)

$286

2 months 22 days ago
(24-Apr-2025)

14/18 (77.78%)

$53.9 (22.83%)

310

Hold

$248

$-6.4 (-2.52%)

$260

2 months 22 days ago
(24-Apr-2025)

2/3 (66.67%)

$11.9 (5.04%)

19

Buy

$285

$30.6 (12.03%)

$250

2 months 22 days ago
(24-Apr-2025)

5/6 (83.33%)

$48.9 (20.71%)

30

Hold

5 months 15 days ago
(31-Jan-2025)

11/11 (100%)

$-7.67 (-3.15%)

212

Buy

$250

$-4.4 (-1.73%)

$215

9 months 16 days ago
(30-Sep-2024)

11/11 (100%)

$6.95 (2.86%)

115

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?